Immuneering IMRX Earnings Call Transcripts

NASDAQ IMRX
$3.89 +0.04 (+1.04%)
As of: Nov 11, 2026 · 11:08 AM EST
1 earnings call on file for Immuneering, Q3 2025. Each transcript opens in a new tab.
Latest earnings call

Immuneering Q3 2025 Earnings Call

Nov 12, 2025 5,480 words · 24 min read
  • Benjamin ZeskindChief Executive Officer
  • Mallory MoralesChief Financial Officer
  • Dr. Allison J. OceanInvestigator
  • Dr. Gregory BataInvestigator
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Immuneering Earnings Call Transcripts

Calls1
LatestNov 12, 2025
SinceQ3 2025

Fiscal 2025

All 1 Immuneering transcript Register to get access to Immuneering’s earnings call transcripts.